Theravance Biopharma Inc (TBPH) Growth Rates Comparisons to Major Pharmaceutical Preparations Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Customers, else..
 
Theravance Biopharma inc   (NASDAQ: TBPH)
 

Theravance Biopharma Inc Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TBPH Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q2 MRQ) -20.86 % 14.14 % 10.17 % 10.9 %
Q / Q Revenue Growth (Q2 MRQ) 17.13 % -17.78 % -10.89 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q2 TTM) 35.11 % 9.25 % 7.99 % %
Sequential Revenue Growth (for 12 months ending Q2 TTM) -4.98 % 2.69 % 2.09 % 2.61 %
Revenue 5 Year Average Growth 8.38 % 7.41 % 8.65 % 10.59 %


TBPH's Growth Comparisons in II. Quarter 2026




Theravance Biopharma Inc 's sharp decrease of -20.86% in sales in the second quarter from the same quarter a year ago, those results deviated strongly from rising Revenue in Major Pharmaceutical Preparations industry with 14.14%, and underperformed the 10.17% Revenue improvement in the Healthcare sector. Comparing the second quarter, sales Theravance Biopharma Inc was trailing overall market not just Major Pharmaceutical Preparations industry.

Top-line improved by 17.13% from the first quarter. Looking into annual sales rise of 8.38%, and S & P 500's average yearly sales growth is 10.59% over the five years, including only Businesses with the second quarter 2026 Results. Theravance Biopharma Inc grew less than the market.

TBPH Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Collaborative Arrangement Revenue
-
-
Yupelri Monotherapy
-
-
Single reportable segment
46.71 %
-
Total
-20.86 %
17.13 %


Growth Rates of TBPH's Income in the second quarter 2026


TBPH Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q2 MRQ) - 4.04 % 11.31 % 97.6 %
Sequential Operating Income Change (Q2 MRQ) - -24.07 % -12.86 % 48.13 %
Y / Y Operating Income Growth (Q2 TTM) - 30.72 % 30.96 % 40.67 %
Sequential Operating Income Growth (Q2 TTM) - -2.28 % 4.91 % 20.86 %
Operating Income 5 Year Avg. Change - 14.39 % 10.39 % 18.76 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q2 MRQ) - -17.06 % -14.53 % 90.69 %
Sequential Income from Cont. Ops. Change (Q2 MRQ) - -26.5 % -63.69 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q2 TTM) 312.92 % 6.22 % 9.85 % 57.33 %
Sequential Income from Cont. Ops. Change (Q2 TTM) -53.02 % -10.03 % -4.69 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change - -0.55 % 0.17 % -28.52 %

TBPH Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q2 MRQ) - -17.52 % -15.05 % 90.69 %
Q / Q Net Income Growth (Q2 MRQ) - -24.43 % -19.05 % 27.07 %
Y / Y Net Income Change (Q2 TTM) 312.92 % 5.2 % 15.48 % 57.33 %
Sequential Net Income Change (Q2 TTM) -53.02 % -10.18 % -6.71 % 18.65 %
Net Income 5 Year Avg. Growth - 14.55 % 9.21 % 22.96 %

TBPH's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q2 MRQ) - -23.21 % -14.53 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q2 MRQ) - -36.1 % -63.69 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q2 TTM) 345.83 % - - -
Sequential EPS from Cont. Ops. Change (Q2 TTM) -52.86 % - - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth - -10.82 % 0.17 % -28.52 %



TBPH EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q2 MRQ) - -23.64 % -15.05 % -28.52 %
Q / Q EPS Net Growth (Q2 MRQ) - -34.3 % -19.05 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q2 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q2 TTM) -53.36 % -7.05 % -4.12 % 4.93 %
EPS Net 5 Year Avg. Change - 14.55 % 9.21 % 22.96 %



Theravance Biopharma Inc reported bottom-line of $ -0.11 in the second quarter, compare to $ 1.08 in the same quarter a year ago. Major Pharmaceutical Preparations industry fell by -23.64%, while Healthcare sector decreased by -15.05%, and overall market improved by 90.69%.

The bottom-line improved by 17.13% from the first quarter. Looking into annual income per share rise of 8.38%, and S & P 500's average yearly income per share growth is 22.96% over the five years, including only Businesses with the second quarter 2026 earnings reports. Theravance Biopharma Inc grew less than the market.

TBPH Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q2 MRQ) - 25.51 % 46.61 % 48.62 %
Sequential Free Cash Flow Change (Q2 MRQ) - -29.98 % -41.09 % 34.18 %
Y / Y Free Cash Flow Change (Q2 TTM) -78.04 % 12.28 % 19.59 % 60.27 %
Sequential Free Cash Flow Change (Q2 TTM) -80 % 3.34 % 5.77 % 15.75 %
Free Cash Flow 5 Year Avg. Change - 1.86 % 0.92 % 7.8 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q2 MRQ) - - - 339.02 %
Sequential Net Cash Flow Change (Q2 MRQ) - - - 216.68 %
Y / Y Net Cash Flow Change (Q2 TTM) -97.38 % - - 209.43 %
Sequential Net Cash Flow Change (Q2 TTM) - - - 152.64 %
Net Cash Flow 5 Year Avg. Change 40.91 % 29.88 % 6.46 % 1.06 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q2 MRQ) - 18.62 % 10.58 % 120.03 %
Sequential Capital Expenditures Change (Q2 MRQ) - -21.14 % -19.64 % 36.87 %
Y / Y Capital Expenditures Change (Q2 TTM) -96.65 % 16.46 % 7.77 % 109.38 %
Sequential Capital Expenditures Change (Q2 TTM) -80.95 % 2.81 % 1.52 % 23.05 %
Capital Expenditures 5 Year Avg. Change -63.65 % 7.84 % 8.61 % 14.74 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.